The scope of the arterial blood gas kits market includes product type, end user, and region. Based on region, the arterial blood gas kits market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the arterial blood gas kits market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID–19 impact analysis across the regions.

According to The Insight Partners’ research, the global arterial blood gas kits market was valued at US$ 455.84 million in 2021 and is likely to hit US$ 773.01 million by 2028, recording a stellar annual growth rate of 7.8% from 2021 to 2028. Increasing prevalence of respiratory diseases and rising cases of metabolic and kidney diseases are the crucial factors credited to the market expansion.

A huge chunk of population suffers from various types of respiratory diseases across the world. Smoking, infections, and genetic elements can cause serious respiratory complications. Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia are among the severe medical conditions exerting a considerable burden on public healthcare system. The American Lung Association reported that over 16.4 million people are diagnosed with COPD, the 3rd leading cause of death in the US. According to the WHO, pneumonia accounted for 15% of deaths of children below 5 years of age in 2017, i.e., 808,694 fatalities in figure worldwide. In respiratory disorders, patients experience trouble in breathing and oxygen shortage. Arterial Blood Gas (ABG) test measures the amount of O2 and CO2 dissolved in arterial blood.

At 7.8% CAGR, the global arterial blood gas kits market is forecasted to be worth US$ 773.01 million by 2028, says The Insight Partners

Get Free Sample PDF Download - https://bit.ly/3LRualz

Huge population suffers from the various types of respiratory diseases across the world. Smoking, infections, and genetic factors can cause respiratory diseases. Chronic obstructive pulmonary disease (COPD), asthma, and pneumonia are a few medical conditions exerting a huge burden on the public healthcare system in various countries worldwide. The American Lung Association reported that COPD is the third leading cause of death in the US, where over 16.4 million people are diagnosed with the condition. Further, according to the US Department of Health and Human Services, around 25 million people in the US had asthma in 2019, which is one of the most common respiratory diseases in the world.

Leading players in the global arterial blood gas kits market are BD; Radiometer Medical ApS; Smiths Group plc; Vyaire Medical, Inc; Opti Medical Systems; Westmed Medical; Siemens Healthineers AG; ITL BioMedical; Teleflex Incorporated; and i-SENS, Inc among others.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information,

please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876